sglt2 inhibitors vs glp 1 agonists Illustration of potential synergistic effects of inhibitor with Hypoglycemia Risk With SGLT2 Inhibitors

Presented for research literature review only Garca-Miranda P et al

Tirzepatide and renal outcomes Tirzepatide Tirzepatide is a dual GIP/GLP-1 receptor agonist designed to engage complementary mechanisms and elicit synergistic and more efficacious responses with respect to monoagonists [39]

doi: 10.1186/s12860-019-0244-x 77 WangPHuangYSunBChenHMaYLiuYet al

If you are currently taking one of these medications or are considering starting, you may be navigating a confusing landscape of information

She is three-four months back to playing soccer and she cant walk without wanting to cry

However, in cases of severe nutrient malabsorption and pernicious anemia, injections are more efficient at correcting the deficiency